Literature DB >> 17991613

5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells.

Katharina Lötzer1, Steffen Jahn, Cornelia Kramer, Markus Hildner, Rolf Nüsing, Colin D Funk, Andreas J R Habenicht.   

Abstract

The 5-lipoxygenase (5-LO) pathway generates lipid mediators, i.e. the cysteinyl leukotrienes (cysLTs) LTC(4)/LTD(4) and LTB(4). CysLT receptors are expressed in endothelial cells (EC) and EC cysLT(2)-R activation induces diverse pro-inflammatory genes in vitro. We now report that LTD(4) promotes formation of an atherosclerosis-protective and anti-thrombotic eicosanoid by markedly up-regulating EC cyclooxygenase-2 (COX-2). CysLT-induced COX-2 transcripts were transiently up-regulated as determined by microarray and QRT-PCR analyses though COX-2 protein remained elevated for several hours. Prostacyclin formation, measured as its stable metabolite 6-keto-PGF(1alpha), was increased several fold in LTD(4)-stimulated ECs, and was inhibited by the COX-2-specific inhibitor, NS-398. COX-2 up-regulation was Ca(2+)-dependent and was partially blocked by cyclosporin A indicating that the 5-LO/COX-2 cross-talk involved signaling through a nuclear factor of activated T cells (NFAT) dependent pathway. Since prostacyclin is a major blood vessel-protective and anti-thrombotic eicosanoid, the EC cysLT(2)-R may limit its otherwise pro-inflammatory actions through a protective Ca(2+)/calcineurin/NFAT-dependent COX-2 feedback loop.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991613     DOI: 10.1016/j.prostaglandins.2007.04.005

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  2 in total

1.  5-(4-Hydroxy-2,3,5-trimethylbenzylidene) thiazolidine-2,4-dione attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesion.

Authors:  Jae-Hoon Choi; Jong-Gil Park; Hyung Jun Jeon; Mi-Sun Kim; Mi-Ran Lee; Mi-Ni Lee; SeongKeun Sonn; Jae-Hong Kim; Mun Han Lee; Myung-Sook Choi; Yong Bok Park; Oh-Seung Kwon; Tae-Sook Jeong; Woo Song Lee; Hyun Bo Shim; Dong Hae Shin; Goo Taeg Oh
Journal:  Exp Mol Med       Date:  2011-08-31       Impact factor: 8.718

2.  Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice.

Authors:  Tolga Uz; Nikola Dimitrijevic; Marta Imbesi; Hari Manev; Radmila Manev
Journal:  Neurosci Lett       Date:  2008-03-21       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.